TrialChinese medical journal2026

First-line atezolizumab monotherapy vs . single-agent chemotherapy in patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum-based therapy: Analysis of the IPSOS Asian subpopulation.

Baohui Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.